Associated Gastroenterologists of Central New York - Fayetteville — Fayetteville, New York

Associated Gastroenterologists of Central New York - Fayetteville is a clinical research site located in Fayetteville, New York, United States 13066.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Associated Gastroenterologists of Central New York - Fayetteville has participated in 1 clinical trials.

Therapeutic areas: Cancer.

Sponsors: Harbinger Health.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fayetteville

Browse all research sites in New York · View every site in Fayetteville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Associated Gastroenterologists of Central New York - Fayetteville?

Associated Gastroenterologists of Central New York - Fayetteville has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Associated Gastroenterologists of Central New York - Fayetteville conducted?

Associated Gastroenterologists of Central New York - Fayetteville has 1 clinical trials on record. Their work covers Cancer.

Is Associated Gastroenterologists of Central New York - Fayetteville accredited by Crixeo Clinical Trials?

Associated Gastroenterologists of Central New York - Fayetteville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Associated Gastroenterologists of Central New York - Fayetteville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.